Mifepristone, which is taken with a second drug, misoprostol, to end an early pregnancy, was first approved by the FDA in 2000 after "a thorough and comprehensive review" determined it was safe ...

The federal Food and Drug Administration has no current plan to bend to pressure from some Republicans to restrict ...

Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad approval of abortion drugs after the Biden administration expanded their use.

“FDA is under one order that says you can do nothing and another that says in seven days I’m going to require you to vacate the approval of mifepristone,” said Glenn Cohen of Harvard Law School.

The FDA approved mifepristone in 2000 as a safe and effective way to end early pregnancies. Currently, there are no in-person requirements and the pill can be sent through the mail.

Mifepristone results in a completed abortion 97.4% of the time, according to U.S. studies cited in the FDA label. But in 2.6% of cases, a surgical intervention is needed.

The FDA is still on track to meet its user fee targets despite a higher-than-normal vacancy rate among scientific reviewers.

Mifepristone is the first pill, followed by the drug misoprostol, for medication abortion in the first 10 weeks of pregnancy, and won FDA approval in 2000.

Mifepristone results in a completed abortion 97.4% of the time, according to U.S. studies cited in the FDA label. But in 2.6% of cases, a surgical intervention is needed.